(MedPage Today) — Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as compared with chemotherapy alone, according to final results from a large randomized trial.
Men with metastatic…
Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/114740
Author :
Publish date : 2025-03-19 21:27:00
Copyright for syndicated content belongs to the linked Source.
